"Thyrotoxicosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Descriptor ID |
D013971
|
| MeSH Number(s) |
C19.874.397.685
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thyrotoxicosis".
Below are MeSH descriptors whose meaning is more specific than "Thyrotoxicosis".
This graph shows the total number of publications written about "Thyrotoxicosis" by people in this website by year, and whether "Thyrotoxicosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thyrotoxicosis" by people in Profiles.
-
Lee H, Hodi FS, Giobbie-Hurder A, Ott PA, Buchbinder EI, Haq R, Tolaney S, Barroso-Sousa R, Zhang K, Donahue H, Davis M, Gargano ME, Kelley KM, Carroll RS, Kaiser UB, Min L. Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy. Cancer Immunol Res. 2017 12; 5(12):1133-1140.
-
Gupta P, Chhabra L, Hiendlmayr B, Spodick DH. Thyrotoxic pericarditis: An underappreciated phenomenon. Int J Cardiol. 2015 Nov 01; 198:32-3.
-
Lubitz SA, Yin X, Rienstra M, Schnabel RB, Walkey AJ, Magnani JW, Rahman F, McManus DD, Tadros TM, Levy D, Vasan RS, Larson MG, Ellinor PT, Benjamin EJ. Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2015 May 12; 131(19):1648-55.
-
Chhabra L, Chaubey VK, Joshi S, Phadke J. Thyrotoxic hypercoagulable state with cerebral venous thrombosis and venous infarction masquerading as epilepsia partialis continua. Neurol India. 2013 Nov-Dec; 61(6):671-3.
-
Vyas AA, Vyas P, Fillipon NL, Vijayakrishnan R, Trivedi N. Successful treatment of thyroid storm with plasmapheresis in a patient with methimazole-induced agranulocytosis. Endocr Pract. 2010 Jul-Aug; 16(4):673-6.
-
Emerson CH, Torres MS. Recombinant human thyroid-stimulating hormone: pharmacology, clinical applications and potential uses. BioDrugs. 2003; 17(1):19-38.
-
Simkin PH, Ramirez LA, Zweizig SL, Afonso SA, Fraire AE, Khan A, Dunn AD, Dunn JT, Braverman LE. Monomorphic teratoma of the ovary: a rare cause of triiodothyronine toxicosis. Thyroid. 1999 Sep; 9(9):949-54.
-
Hollingsworth HM, Pratter MR, Dubois JM, Braverman LE, Irwin RS. Effect of triiodothyronine-induced thyrotoxicosis on airway hyperresponsiveness. J Appl Physiol (1985). 1991 Aug; 71(2):438-44.